FDA announces two initiatives to accelerate drug development

被引：0

|

作者：

不详

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2006年 / 5卷 / 02期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：95 / 95

页数：1

相关论文

共 50 条

[1] FDA ANNOUNCES 4 INITIATIVES FOR DRUG APPROVAL SYSTEM
不详
CLINICAL PHARMACY, 1992, 11 (07): : 574 - &
[2] US FDA announces initiatives to improve patient safety
Reactions Weekly, 2003, 943 (1) : 3 - 3
[3] FDA Critical Path Initiatives: Opportunities for Generic Drug Development
Robert A. Lionberger
The AAPS Journal, 2008, 10 : 103 - 109
[4] FDA critical path initiatives: Opportunities for generic drug development
Lionberger, Robert A.
AAPS JOURNAL, 2008, 10 (01): : 103 - 109
[5] FDA ANNOUNCES REFORMS OF DRUG REVIEW PROCESS
ANDERSON, C
NATURE, 1991, 354 (6350) : 173 - 173
[6] FDA announces steps to increase efficiency in preliminary stages of innovative drug development
不详
JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (03) : 110 - 110
[7] White House announces cancer-drug initiatives
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (10) : 1110 - 1110
[8] FDA announces new office of oncology drug products
不详
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16): : 1199 - 1199
[9] US FDA announces guidance on drug name confusion
Reactions Weekly, 2001, 846 (1) : 2 - 2
[10] FDA Announces 2012 Prescription-Drug User Fees
Ritter, Amy
BIOPHARM INTERNATIONAL, 2011, 24 (09) : 16 - 16

← 1 2 3 4 5 →